- ►annals.org JR Schofield, WA Robinson, JR Murphy, DK … - Annals of internal medicine, 1994 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To determine the toxicity and efficacy of low-dose interferon- ... Cited by 45 - Related articles - BL Direct - All 3 versions
- ►bloodjournal.org [PDF] H Ozer, SL George, CA Schiffer, K Rao, PN Rao … - Blood, 1993 - Am Soc Hematology . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 148 - Related articles - BL Direct - All 4 versions
FX Mahon, M Montastruc, C Faberes, J … - Blood, 1994 - ncbi.nlm.nih.gov 1: Blood. 1994 Nov 15;84(10):3592-4. Comment on: Blood. 1993 Nov
15;82(10):2975-84. Predicting complete cytogenetic response in ... Cited by 38 - Related articles - All 3 versions
[CITATION] Prolonged survival following achievement of cytogenetic response with alpha interferon …
B Anger, F Porzsolt, R Leichtle, B Heinze, C … - Annals of Hematology, 1989 - Springer Summary. Nine previously untreated patients with Philadelphia
chromosome-positive chronic myelo- cytic leukemia (CML) were treated with recom-
binant interferon alpha 2a (rlFN-alpha 2a) and hydroxyurea. Patients ... Cited by 19 - Related articles - All 3 versions
M Freund, P Von Wussow, H Diedrich, R Eisert … - Br J Haematol, 1989 - interscience.wiley.com Summary. Twenty-seven patients with Philadelphia chromosome positive chronic
myelogenous leukaemia in the chronic phase were treated with low doses of
recombinant interferon (IFN) alpha-2b. Ten patients entered a complete and ... Cited by 74 - Related articles - All 2 versions
- ►hematologylibrary.org [PDF] G Alimena, E Morra, M Lazzarino, AM Liberati, … - Blood, 1988 - bloodjournal.hematologylibrary.org . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 137 - Related articles - All 5 versions
O Kloke, N Niederle, JY Qiu, U Wandl, T … - British journal of haematology, 1993 - interscience.wiley.com Summary. The objective of this study was to investigate the prognostic impact of
the reduction of Philadelphia chromosome (Ph) positive metaphases by treatment
of chronic myelogenous leukaemia (CML) with interferon (IFN) alpha. ... Cited by 64 - Related articles - BL Direct - All 3 versions
- ►hematologylibrary.org [PDF] K Ohnishi, R Ohno, M Tomonaga, N Kamada, … - Blood, 1995 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 167 - Related articles - BL Direct - All 4 versions
- ►jcojournal.org [PDF] HM Kantarjian, MJ Keating, EH Estey, S O' … - Journal of Clinical Oncology, 1992 - jcojournal.org Purpose: To evaluate the efficacy of interferon-a (IFN-A) and low-dose
cytarabine (arc-C) combination chemotherapy in patients with chronic myelogenous
leu- kemia (CML). Patients and Methods: Sixty patients with advanced phases ... Cited by 94 - Related articles - All 6 versions
